Details for Patent: 7,351,723

Which drugs does patent 7,351,723 protect, and when does it expire?

Patent 7,351,723 protects PROTONIX IV and is included in one NDA.

Protection for PROTONIX IV has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has fifty-eight patent family members in forty countries.

Summary for Patent: 7,351,723

Title:	Freeze-dried pantoprazole preparation and pantoprazole injection
Abstract:	Lyophilized pantoprazole preparations which are obtainable by freeze-drying of an aqueous solution of pantoprazole, ethylenediamine tetraacetic acid and/or a suitable salt thereof, and sodium hydroxide and/or sodium carbonate are disclosed. The preparations have advantageous properties when reconstituted for injection.
Inventor(s):	Linder; Rudolf (Constance, DE), Dietrich; Rango (Constance, DE)
Assignee:	Nycomed GmbH (Constance, DE)
Application Number:	10/855,703
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 7,351,723

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Wyeth Pharms	PROTONIX IV	pantoprazole sodium	INJECTABLE;INTRAVENOUS	020988-001	Mar 22, 2001	AP	RX	Yes	Yes

Foreign Priority and PCT Information for Patent: 7,351,723

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	00125569	Nov 22, 2000

International Family Members for US Patent 7,351,723

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	034277
Argentina	092374
Austria	381946
Australia	1604202
Australia	2002216042